Active immunization against nicotine dependence
Author: De Villiers, Sabina
Date: 2010-04-09
Location: Farmakologens föreläsningssal, Nanna Swartz väg 2
Time: 09.00
Department: Institutionen för fysiologi och farmakologi / Department of Physiology and Pharmacology
View/ Open:
Thesis (544.8Kb)
Abstract
Tobacco smoking is the largest preventable cause of morbidity and premature mortality in the world. Although its medical consequences are well documented, 20-45% of the adult population in the European countries remains tobacco smokers. The drugs presently used in smoking cessation have limited efficiency and, therefore, there is a need for alternative and improved treatments. A novel type of drug in this regard may be provided by using active immunization against nicotine, i.e. nicotine vaccines. The rationale is to generate endogenous anti-nicotine antibodies that bind nicotine in the blood, thereby preventing it from reaching the brain where it exerts its reinforcing effects. Since nicotine is a small molecule, unable to elicit an immune response, it has to be coupled to a carrier protein via a linker.
In this thesis a series of novel nicotine immunogens, including structurally different linkers coupled to the 5- or 6-position of the nicotine molecule and conjugated to a carrier protein, were studied. The amounts of antibodies generated and their selectivity were assessed by ELISA techniques, and all immunogens generated anti-nicotine antibodies that recognized (S)-nicotine or nornicotine better than the other nicotine metabolites tested. In addition, no cross-reactivity to endogenous transmitters was detected. In vivo voltammetry was used to assess the nicotine-induced increase in dopamine release in the shell region of the nucleus accumbens, a neurochemical correlate to nicotine s rewarding properties, and our work revealed that this effect of nicotine was differentially affected depending on both the immunogen studied and the selectivity of the antibodies. The nicotine immunogen IP18-KLH, showing a favorable antibody selectivity profile, prevented the nicotine-induced dopamine release and, likewise, the reinstatement of nicotine-seeking behavior in previously self-administering rats. These effects of the immunization with IP18-KLH were found to be associated with an altered distribution of nicotine, resulting in elevated nicotine levels in serum, due to antibody binding, and consequently a retarded nicotine distribution to the brain.
Taken together our results provide substantial preclinical support for the potential utility of nicotine vaccines in the treatment of nicotine dependence, notably relapse prevention.
In this thesis a series of novel nicotine immunogens, including structurally different linkers coupled to the 5- or 6-position of the nicotine molecule and conjugated to a carrier protein, were studied. The amounts of antibodies generated and their selectivity were assessed by ELISA techniques, and all immunogens generated anti-nicotine antibodies that recognized (S)-nicotine or nornicotine better than the other nicotine metabolites tested. In addition, no cross-reactivity to endogenous transmitters was detected. In vivo voltammetry was used to assess the nicotine-induced increase in dopamine release in the shell region of the nucleus accumbens, a neurochemical correlate to nicotine s rewarding properties, and our work revealed that this effect of nicotine was differentially affected depending on both the immunogen studied and the selectivity of the antibodies. The nicotine immunogen IP18-KLH, showing a favorable antibody selectivity profile, prevented the nicotine-induced dopamine release and, likewise, the reinstatement of nicotine-seeking behavior in previously self-administering rats. These effects of the immunization with IP18-KLH were found to be associated with an altered distribution of nicotine, resulting in elevated nicotine levels in serum, due to antibody binding, and consequently a retarded nicotine distribution to the brain.
Taken together our results provide substantial preclinical support for the potential utility of nicotine vaccines in the treatment of nicotine dependence, notably relapse prevention.
List of papers:
I. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Malmerfelt A, Johansson AM, Svensson TH (2002). Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell. Respiration. 69(3): 247-53.
Pubmed
II. Lindblom N, de Villiers SH, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2002). Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration. 69(3): 254-60.
Pubmed
III. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2004). Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat. Naunyn Schmiedebergs Arch Pharmacol. 370(4): 299-304. Epub 2004 Sep 16.
Pubmed
IV. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Baraznenok I, Malmerfelt A, Marcus MM, Johansson AM, Svensson TH (2010). Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure. Vaccine. 28(10): 2161-8. Epub 2010 Jan 7.
Pubmed
I. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Malmerfelt A, Johansson AM, Svensson TH (2002). Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell. Respiration. 69(3): 247-53.
Pubmed
II. Lindblom N, de Villiers SH, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2002). Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration. 69(3): 254-60.
Pubmed
III. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2004). Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat. Naunyn Schmiedebergs Arch Pharmacol. 370(4): 299-304. Epub 2004 Sep 16.
Pubmed
IV. de Villiers SH, Lindblom N, Kalayanov G, Gordon S, Baraznenok I, Malmerfelt A, Marcus MM, Johansson AM, Svensson TH (2010). Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure. Vaccine. 28(10): 2161-8. Epub 2010 Jan 7.
Pubmed
Issue date: 2010-03-19
Rights:
Publication year: 2010
ISBN: 978-91-7409-829-7
Statistics
Total Visits
Views | |
---|---|
Active ...(legacy) | 961 |
Active ... | 153 |
Total Visits Per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
Active ... | 2 | 0 | 0 | 0 | 2 | 0 | 0 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 444 |
thesis.pdf | 141 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 432 |
Sweden | 106 |
Germany | 68 |
China | 61 |
Russia | 30 |
South Korea | 21 |
United Kingdom | 14 |
Denmark | 13 |
Finland | 10 |
Ireland | 10 |
Top cities views
Views | |
---|---|
Sunnyvale | 43 |
Romeo | 41 |
Stockholm | 31 |
Beijing | 30 |
Kiez | 28 |
Seoul | 21 |
Ashburn | 13 |
Ballerup | 11 |
London | 11 |
Dublin | 10 |